Management strategies in antithrombotic therapy [[electronic resource] /] / by Arman Askari and Adrian W. Messerli |
Autore | Askari Arman T |
Pubbl/distr/stampa | Chichester ; ; Hoboken, N.J., : John Wiley and Sons, c2007 |
Descrizione fisica | 1 online resource (372 p.) |
Disciplina | 616.1/42 |
Altri autori (Persone) | MesserliAdrian W |
Soggetto topico |
Thrombolytic therapy
Thrombosis - Treatment Fibrinolytic agents |
ISBN |
1-282-34825-6
9786612348259 0-470-51813-8 0-470-51814-6 |
Formato | Materiale a stampa ![]() |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Nota di contenuto | Thrombosis and antithrombotics in vascular disease -- Aspirin -- Thienopyridines, ticlopidine, and clopidogrel -- Platelet glycoprotein IIb/IIIa inhibitors -- Unfractionated heparin -- Low-molecular-weight heparins -- Direct thrombin inhibitors -- Fibrinolytic agents -- Acute ST-segment elevation myocardial infarction -- Acute coronary syndromes / non-ST-segment elevation myocardial infarction -- Anticoagulation strategies for patients undergoing percutaneous coronary intervention -- Venous thromboembolic disease -- Heparin-induced thrombocytopenia. |
Record Nr. | UNINA-9910829111903321 |
Askari Arman T
![]() |
||
Chichester ; ; Hoboken, N.J., : John Wiley and Sons, c2007 | ||
![]() | ||
Lo trovi qui: Univ. Federico II | ||
|
Therapeutic Strategies in Thrombosis [[electronic resource]] |
Autore | Kristensen S. D. <1955-> |
Pubbl/distr/stampa | Oxford, : Atlas Medical Publishing Ltd, 2005 |
Descrizione fisica | 1 online resource (405 p.) |
Disciplina | 616.13506 |
Altri autori (Persone) |
De CaterinaR. <1954->
MoliternoDavid J |
Collana | Therapeutic Strategies |
Soggetto topico |
Thrombolytic therapy
Thrombosis -- Treatment Thrombosis Cardiovascular Diseases Medicine Health & Biological Sciences |
ISBN |
1-280-30995-4
9786610309955 1-84692-543-6 |
Formato | Materiale a stampa ![]() |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Nota di contenuto |
Contents; Contributors; 1. Arterial thrombosis: a brief overview; 2. Aspirin: a risk-based strategy; 3. Clopidogrel and other platelet ADP inhibitors; 4. Glycoprotein IIb/IIIa inhibitors; 5. Unfractionated heparin and low-molecular-weight heparin in coronary heart disease; 6. Intravenous direct thrombin inhibition: acute coronary syndromes and heparin-induced thrombocytopaenia; 7. Direct thrombin inhibition during percutaneous coronary interventions; 8. Pentasaccharide and other factor Xa inhibitors
9. Direct thrombin inhibition - thromboprophylaxis, deep venous thrombosis, atrial fibrillation and coronary artery disease10. Warfarin after acute myocardial infarction; 11. Thrombolytic therapy and concomitantantithrombotic therapy; 12. Pre-hospital reperfusion therapy; 13. Antithrombotic strategies in patients undergoing primary percutaneous intervention; 14. Antithrombotic management in patients with prosthetic valves; 15. Stroke: thrombolysis and antithrombotic therapy; 16. Atrial fibrillation: antithrombotic therapy; 17, Venous thromboembolism: pathophysiology and diagnosis 18. Antithrombotic therapy in venous thrombosis and pulmonary embolism19.Prevention and treatment of venous and arterial thrombosis in patients with specific conditions: diabetes, hypercoagulable states, pregnancy and renal diseases; 20. Monitoring of antithrombotic drugs; Index |
Record Nr. | UNISA-996339091403316 |
Kristensen S. D. <1955->
![]() |
||
Oxford, : Atlas Medical Publishing Ltd, 2005 | ||
![]() | ||
Lo trovi qui: Univ. di Salerno | ||
|